In particular, anti-sporozoite and anti-CSP antibodies have influenced malaria vaccine development, notably the RTS,S vaccine (Spitalny and Nussenzweig, 1973; Milich et al., 2001; Chappel et al., 2004; White et al., 2015). This evidence concerns the gene DNAJC5 and malaria.